Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Advocacy groups Friday cheered the new list of selected drugs and urged the Trump administration to continue the negotiations. Some Republicans have called for ending or overhauling the initiative ...

“Every time a new list (of drugs) comes out ... Ofev, which treats idiopathic pulmonary fibrosis. • Linzess, which treats chronic idiopathic constipation and irritable bowel syndrome with ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.